Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.41 |
| ▸ | BACE1 | P56817 | 9/20 | 0.35 |
| ▸ | BACE2 | Q9Y5Z0 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6609077 | 0.84 | BACE1 (0.34) | PDK2BACE1BACE2MAPK1ALDH1A1 | |
| SCHEMBL23206456 | 0.80 | ALDH1A1 (0.42) | PDK2BACE1BACE2TSHRGLA | |
| SCHEMBL12983307 | 0.73 | PDK2 (0.40) | PDK2BACE1BACE2GAAMAPK1 | |
| SCHEMBL38655265 | 0.73 | PDK2 (0.47) | PDK2POLBMAPK1ALDH1A1LMNA | |
| SCHEMBL16764551 | 0.70 | ALDH1A1 (0.45) | PDK2KIF11ALDH1A1LMNAMAPT | |
| Hydrochloric Acid SCHEMBL32670447 | 0.68 | ALDH1A1 (0.43) | KIF11ALDH1A1LMNAMAPTTDP1 | |
| SCHEMBL30212897 | 0.68 | TSHR (0.44) | PDK2TSHRGLAPOLBGAA | |
| SCHEMBL24028220 | 0.68 | TSHR (0.44) | PDK2TSHRGLAPOLBGAA | |
| SCHEMBL38657142 | 0.68 | — | — | |
| SCHEMBL21543374 | 0.67 | PDK2 (0.43) | PDK2GAAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102082-A1 | ALKYLPHENYL SUBSTITUTED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | DEEP APPLE THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260132119-A1 | Alkylphenyl Substituted Compounds, Compositions and Methods of Use | DEEP APPLE THERAPEUTICS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132119-A1 | Alkylphenyl Substituted Compounds, Compositions and Methods of Use | GIPR, MC2R, GRPR | PDK2 2899/4885BACE1 4082/4885BACE2 3350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.